136 related articles for article (PubMed ID: 33264610)
1. miR-29 Sustains B Cell Survival and Controls Terminal Differentiation via Regulation of PI3K Signaling.
Hines MJ; Coffre M; Mudianto T; Panduro M; Wigton EJ; Tegla C; Osorio-Vasquez V; Kageyama R; Benhamou D; Perez O; Bajwa S; McManus MT; Ansel KM; Melamed D; Koralov SB
Cell Rep; 2020 Dec; 33(9):108436. PubMed ID: 33264610
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
3. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
[TBL] [Abstract][Full Text] [Related]
4. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.
Zhao C; Sun W; Zhang P; Ling S; Li Y; Zhao D; Peng J; Wang A; Li Q; Song J; Wang C; Xu X; Xu Z; Zhong G; Han B; Chang YZ; Li Y
RNA Biol; 2015; 12(3):343-53. PubMed ID: 25826666
[TBL] [Abstract][Full Text] [Related]
5. Imbalanced PTEN and PI3K Signaling Impairs Class Switch Recombination.
Chen Z; Getahun A; Chen X; Dollin Y; Cambier JC; Wang JH
J Immunol; 2015 Dec; 195(11):5461-5471. PubMed ID: 26500350
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
Tu K; Liu Z; Yao B; Han S; Yang W
Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293
[TBL] [Abstract][Full Text] [Related]
7. miR-132-3p boosts caveolae-mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav-1 signaling pathway.
Gu Y; Cai R; Zhang C; Xue Y; Pan Y; Wang J; Zhang Z
FASEB J; 2019 Jan; 33(1):441-454. PubMed ID: 30024792
[TBL] [Abstract][Full Text] [Related]
8. Regulation of B-cell activation and differentiation by the phosphatidylinositol 3-kinase and phospholipase Cgamma pathway.
Marshall AJ; Niiro H; Yun TJ; Clark EA
Immunol Rev; 2000 Aug; 176():30-46. PubMed ID: 11043766
[TBL] [Abstract][Full Text] [Related]
9. Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation.
Baracho GV; Miletic AV; Omori SA; Cato MH; Rickert RC
Curr Opin Immunol; 2011 Apr; 23(2):178-83. PubMed ID: 21277760
[TBL] [Abstract][Full Text] [Related]
10. A c-Myc/miR17-92/Pten Axis Controls PI3K-Mediated Positive and Negative Selection in B Cell Development and Reconstitutes CD19 Deficiency.
Benhamou D; Labi V; Novak R; Dai I; Shafir-Alon S; Weiss A; Gaujoux R; Arnold R; Shen-Orr SS; Rajewsky K; Melamed D
Cell Rep; 2016 Jul; 16(2):419-431. PubMed ID: 27346348
[TBL] [Abstract][Full Text] [Related]
11. Role of PI3K in the generation and survival of B cells.
Werner M; Hobeika E; Jumaa H
Immunol Rev; 2010 Sep; 237(1):55-71. PubMed ID: 20727029
[TBL] [Abstract][Full Text] [Related]
12. Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486.
Small EM; O'Rourke JR; Moresi V; Sutherland LB; McAnally J; Gerard RD; Richardson JA; Olson EN
Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4218-23. PubMed ID: 20142475
[TBL] [Abstract][Full Text] [Related]
13. miR-29b regulates Ang II-induced EMT of rat renal tubular epithelial cells via targeting PI3K/AKT signaling pathway.
Hu H; Hu S; Xu S; Gao Y; Zeng F; Shui H
Int J Mol Med; 2018 Jul; 42(1):453-460. PubMed ID: 29568897
[TBL] [Abstract][Full Text] [Related]
14. The targeted regulation of miR-26a on PTEN-PI3K/AKT signaling pathway in myocardial fibrosis after myocardial infarction.
Zhang S; Cui R
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):523-531. PubMed ID: 29424913
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
16. The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis.
Henao-Mejia J; Williams A; Goff LA; Staron M; Licona-Limón P; Kaech SM; Nakayama M; Rinn JL; Flavell RA
Immunity; 2013 May; 38(5):984-97. PubMed ID: 23623381
[TBL] [Abstract][Full Text] [Related]
17. Thidiazuron suppresses breast cancer via targeting miR-132 and dysregulation of the PI3K-Akt signaling pathway mediated by the miR-202-5p-PTEN axis.
Ibrahim HM; Ismail MB; Ammar RB; Ahmed EA
Biochem Cell Biol; 2021 Jun; 99(3):374-384. PubMed ID: 33103467
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway.
Chai C; Song LJ; Han SY; Li XQ; Li M
CNS Neurosci Ther; 2018 May; 24(5):369-380. PubMed ID: 29316313
[TBL] [Abstract][Full Text] [Related]
19. miRNAs Are Essential for the Regulation of the PI3K/AKT/FOXO Pathway and Receptor Editing during B Cell Maturation.
Coffre M; Benhamou D; Rieß D; Blumenberg L; Snetkova V; Hines MJ; Chakraborty T; Bajwa S; Jensen K; Chong MMW; Getu L; Silverman GJ; Blelloch R; Littman DR; Calado D; Melamed D; Skok JA; Rajewsky K; Koralov SB
Cell Rep; 2016 Nov; 17(9):2271-2285. PubMed ID: 27880903
[TBL] [Abstract][Full Text] [Related]
20. MiR-21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway.
Gui F; Hong Z; You Z; Wu H; Zhang Y
Cell Biol Int; 2016 Dec; 40(12):1294-1302. PubMed ID: 27600360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
